73 results match your criteria: "is Clinical Pharmacy Specialist[Affiliation]"
Am J Health Syst Pharm
June 2015
Kristen Hillebrand, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Critical Care, Cardiovascular Intensive Care Unit/Burns Special Care Unit, University of Cincinnati Medical Center, Cincinnati, OH. Corey J. Leinum, Pharm.D., BCPS, is Clinical Pharmacist, University of Minnesota Medical Center, Fairview, Minneapolis. Sonya Desai, Pharm.D., BCPS, is Clinical Pharmacy Manager, Pediatrics, and Clinical Pharmacotherapy Specialist, Pediatric and Neonatal Critical Care, Department of Pharmacy Division of Pharmacotherapy, New York University Langone Medical Center, New York. Natasha N. Pettit, Pharm.D., BCPS (AQ-ID), is Clinical Pharmacy Specialist, Infectious Diseases, and Pharmacy Director, Antimicrobial Stewardship Program, Department of Pharmacy, University of Chicago Medicine, Chicago, IL. Patrick D. Fuller, Pharm.D., BCPS, is Pharmacy Staff Development Coordinator and Postgraduate Year 1 Residency Program Director, Nebraska Medicine, Omaha.
Purpose: The current use and content of screening tools utilized by ASHP-accredited pharmacy residency programs were assessed.
Methods: A survey consisting of 19 questions assessing residency programs and the screening of pharmacy residency program applicants was e-mailed to residency directors of 362 pharmacy residency programs at 105 University HealthSystem Consortium (UHC)-member institutions. Questions gathered general program demographic information, data related to applicant growth from residency years 2010-11 to 2011-12, and information about the residency screening processes currently used.
Am J Health Syst Pharm
June 2015
Robert S. Pugliese, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Emergency Medicine, Thomas Jefferson University Hospital, and Clinical Assistant Professor, School of Pharmacy, Thomas Jefferson University, Philadelphia, PA. Evan J. Slagle, Pharm.D., is Postgraduate Year 1 Pharmacy Practice Resident, Department of Pharmacy, Saint Joseph Medical Center, Reading, PA. Glenn R. Oettinger, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Emergency Medicine, Thomas Jefferson University Hospital, and Clinical Assistant Professor, School of Pharmacy, Thomas Jefferson University. Kenneth J. Neuburger, M.D., is Clinical Assistant Professor of Emergency Medicine, Department of Emergency Medicine, Thomas Jefferson University. Timothy M. Ambrose, M.D., is Epilepsy Fellow, Department of Neurology, Thomas Jefferson University Hospital.
Purpose: A case of subacute combined degeneration (SCD) of the spinal cord manifesting as severe ataxia and urinary retention in a patient with a history of heavy nitrous oxide abuse and self-supplementation with cyanocobalamin is reported.
Summary: A 27-year-old woman was treated in the emergency department for complaints of abdominal pain and inability to urinate for about 12 hours. The patient also complained of worsening lower-extremity weakness for 10 days and a "pins and needles" sensation in the lower extremities for approximately 1 year.
Am J Health Syst Pharm
May 2015
Angela Q. Maldonado, Pharm.D., BCPS, CPP, is Clinical Pharmacy Specialist, Department of Transplant Surgery, Vidant Medical Center, Greenville, NC. Eric M. Tichy, Pharm.D., FCCP, BCPS, is Clinical Pharmacy Specialist, Department of Pharmacy, Yale-New Haven Hospital, New Haven, CT. Christin C. Rogers, Pharm.D., FCCP, BCPS, is Clinical Pharmacy Coordinator, Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA. MayaCampara, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Department of Pharmacy, University of Illinois at Chicago. ChristopherEnsor, Pharm.D., BCPS, is Clinical Pharmacy Specialist, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA. ChristinaT. Doligalski, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Department of Pharmacy, Tampa General Hospital, Tampa, FL. Steven Gabardi, Pharm.D., FCCP, BCPS, is Clinical Pharmacy Specialist, Departments of Transplant Surgery and Pharmacy and Renal Division, Brigham and Women's Hospital, Boston, MA. JillianL. Descourouez, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Department of Pharmacy, University of Wisconsin Hospital and Clinics, Madison. Ian C. Doyle, Pharm.D., BCPS, is Assistant Professor, School of Pharmacy, Pacific University, Hillsboro, OR. JenniferTrofe-Clark, Pharm.D., FCCP, BCPS, is Clinical Pharmacy Specialist, Department of Pharmacy Services, Hospital of the University of Pennsylvania, Philadelphia, and Adjunct Associate Professor, Renal Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania.
Purpose: Pharmacotherapy concerns and other factors with a bearing on patient selection for kidney transplantation are discussed.
Summary: The process of selecting appropriate candidates for kidney transplantation involves multidisciplinary assessment to evaluate a patient's mental, social, physical, financial, and medical readiness for successful surgery and good posttransplantation outcomes. Transplantation pharmacists can play important roles in the recognition and stratification of pharmacologic and nonpharmacologic risks in prospective kidney transplant recipients and the identification of issues that require a mitigation strategy.
Am J Health Syst Pharm
May 2015
Vi Gilmore, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Internal Medicine; Leigh Efird, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Internal Medicine; and Denise Fu, Pharm.D., BCACP, is Clinical Coordinator, Johns Hopkins Home Care Group, The Johns Hopkins Hospital, Baltimore, MD. Yvonne LeBlanc, Pharm.D., M.B.A., is Inpatient Pharmacist, Lahey Hospital and Medical Center, Burlington, MA; at the time of writing, she was Outpatient Clinical Programs Manager, Johns Hopkins Home Care Group. Todd Nesbit, Pharm.D., M.B.A., is Associate Director, Decentralized and Clinical Services, The Johns Hopkins Hospital. Meghan Swarthout, Pharm.D., M.B.A., BCPS, is Division Director, Ambulatory and Care Transitions, The Johns Hopkins Hospital, and Associate Director, Clinical Services, Johns Hopkins Outpatient Pharmacy, Johns Hopkins Home Care Group.
Purpose: The implementation of a practice model designed to reduce hospital readmissions through optimal deployment of pharmacy staff on multidisciplinary care collaboration teams is described.
Summary: In response to Affordable Care Act provisions aimed at reducing preventable hospital readmissions, the pharmacy department at The Johns Hopkins Hospital (JHH) led the implementation of a new pharmacy services model spanning both inpatient and outpatient settings. Key components of the model include (1) increased pharmacist participation in multidisciplinary rounds, (2) targeted medication reconciliation and patient education, (3) postdischarge phone monitoring of selected patients, and (4) bedside discharge medication delivery performed by a "transitions pharmacist extender.
Am J Health Syst Pharm
April 2015
Emma L. Ross, Pharm.D., is Pediatric Clinical Pharmacist, American Family Children's Hospital, UW Hospital and Clinics, Madison, WI; at the time of writing she was Pharmacy Practice Resident, Department of Pharmacy, Children's Hospital Colorado, Aurora. Justin Heizer, Pharm.D., is Postgraduate Year 1 Pharmacy Practice Resident; and Mark A. Mixon, Pharm.D., is Postgraduate Year 1 Pharmacy Practice Resident, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado (UC), Aurora. Jennifer Jorgensen, Pharm.D., is Clinical Pharmacist, General Medicine, Department of Pharmacy, Children's Hospital Colorado. Connie A. Valdez, Pharm.D., M.S.Ed., BCPS, is Associate Professor, Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, UC. Angela S. Czaja, M.D., M.Sc., is Associate Professor and Associate Fellowship Director, Division of Critical Care, Department of Pediatrics, School of Medicine, and Center for Pharmaceutical Outcomes Research, Skaggs School of Pharmacy and Pharmaceutical Sciences, UC. Pamela D. Reiter, Pharm.D., is Clinical Pharmacy Specialist, Pediatric Intensive Unit, Department of Pharmacy, Children's Hospital Colorado, and Clinical Associate Professor of Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, UC.
Purpose: The development and use of a decision support tool to help formulate recommendations for dosing of commonly prescribed medications in critically ill obese children are described.
Methods: Medications prescribed in 2010 to critically ill infants and children (younger than 18 years) were identified from the Pediatric Health Information System. The most commonly prescribed and therapeutically monitored medications were extracted.
Am J Health Syst Pharm
March 2015
Kristen T. Hedrick, Pharm.D., is Clinical Pharmacy Specialist, Department of Clinical Pharmacy, HealthSpan, Brooklyn Heights, OH. Shannon M. Just, Pharm.D., CACP, is Clinical Pharmacy Specialist and Supervisor, Medication Management Clinic, Department of Clinical Pharmacy, HealthSpan, Parma, OH. Daniel R. Kahn, D.O., is Nephrologist, Department of Nephrology, HealthSpan Physicians, Cleveland Heights, OH.
Purpose: A probable case of severe drug-induced hyponatremia associated with boceprevir use is reported.
Summary: A 55-year-old woman was started on boceprevir (800 mg orally thrice daily) during week 5 of triple therapy for chronic hepatitis C. Her serum sodium concentration the morning before starting boceprevir use was 140 mmol/L.
Am J Health Syst Pharm
March 2015
Vi Doan, Pharm.D., is Postgraduate Year 2 Oncology Pharmacy Resident; Alice Wang, Pharm.D., BCOP, is Clinical Pharmacy Specialist; and Hillary Prescott, Pharm.D., BCOP, is Clinical Pharmacy Specialist, University of Texas MD Anderson Cancer Center, Houston.
Purpose: The pharmacology, pharmacokinetics, efficacy, and safety of the tyrosine kinase inhibitor (TKI) bosutinib in the management of chronic myeloid leukemia (CML) are reviewed.
Summary: Although clinical outcomes are favorable in patients wth Philadelphia chromosome (Ph)-positive CML who receive first-line TKI therapy with imatinib, dasatinib, and nilotinib, disease progression or relapse may occur. Thus, effective second-line agents are crucial.
Am J Health Syst Pharm
March 2015
Melanie Geer, Pharm.D., BCPS, is Clinical Pharmacy Specialist; Donald Mark Potter, M.D., is Endocrinologist; and Heather Ulrich, Pharm.D., BCPS, CDE, is Clinical Pharmacy Specialist, Lebanon Veterans Affairs Medical Center, Lebanon, PA.
Purpose: Published evidence on bedtime versus prebreakfast administration of levothyroxine is reviewed.
Summary: Because levothyroxine absorption has been shown to increase when the drug is administered to patients in a fasted state, the standard recommendation is that levothyroxine be taken one half to one hour prior to breakfast and at least four hours before or after potentially interacting drugs. However, compliance with this recommendation may be problematic for patients with unpredictable or variable schedules.
Am J Health Syst Pharm
February 2015
Kari L. Olson, Pharm.D., is Clinical Pharmacy Supervisor, Clinical Pharmacy Cardiac Risk Service, Pharmacy Department, Kaiser Permanente Colorado (KPCO), Aurora, and Clinical Associate Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora. Adriane N. Irwin, M.S., Pharm.D., is Clinical Assistant Professor, Oregon State University College of Pharmacy, Corvallis; at the time of writing, she was Clinical Pharmacy Research Fellow, Pharmacy Department, KPCO. Sarah J. Billups, Pharm.D., is Clinical Pharmacy Specialist, Clinical Pharmacy Research Team (CPRT), Pharmacy Department, KPCO, and Clinical Assistant Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. Thomas Delate, Ph.D., M.S., is Clinical Pharmacy Research Scientist, CPRT, Pharmacy Department, KPCO, and Clinical Instructor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. Samuel G. Johnson, Pharm.D., is Clinical Pharmacy Specialist, Applied Pharmacogenomics, Pharmacy Department, KPCO, and Clinical Instructor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. Deanna Kurz, Pharm.D., B.A., CCRP, is Senior Project Manager, CPRT, Pharmacy Department, KPCO. Daniel M. Witt, Pharm.D., FCCP, BCPS, is Professor (Clinical) and Vice Chair, Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City; at the time of writing, he was Senior Manager, Clinical Pharmacy Research and Applied Pharmacogenomics, Department of Pharmacy, KPCO.
Purpose: A successful initiative by Kaiser Permanente Colorado (KPCO) to support pharmacy resident research projects and the publication of project results in peer-reviewed journals is described.
Methods: An observational study was conducted to evaluate the publication rates for resident research projects before and after the KPCO pharmacy department established a Clinical Pharmacy Research Team (CPRT) to encourage and enable resident research. All projects presented by KPCO residents at the annual Western States Conference (WSC) for Pharmacy Residents, Fellows, and Preceptors in the 10 years before the CPRT was established (1994-2004, the pre-CPRT group) and the 7 years after CPRT implementation (2005-11, the CPRT group) were included in the analysis.
Am J Health Syst Pharm
February 2015
Samuel L. Aitken, Pharm.D., BCPS, is Clinical Pharmacy Specialist in Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston. Eric M. Tichy, Pharm.D., FCCP, BCPS, is Senior Clinical Pharmacy Specialist, Solid Organ Transplantation, and Director, Postgraduate Year 2 Residency, Department of Pharmacy Services, Yale-New Haven Hospital, New Haven, CT.
Am J Health Syst Pharm
February 2015
Megan A. Rech, Pharm.D., BCPS, is Emergency Medicine Clinical Pharmacist, Loyola University Medical Center, Maywood, IL. Sarah A. Day, Pharm.D., BCPS, is Clinical Pharmacist, Critical Care, Doctors Hospital, Columbus, OH. Jenna M. Kast, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Critical Care, Beaumont Hospital, Royal Oak, MI. Elisabeth E. Donahey, Pharm.D., BCPS, is Neurosciences Intensive Care Pharmacist, Loyola University Medical Center. Mehrnaz Pajoumand, Pharm.D., BCPS, is Clinical Specialist, Trauma Critical Care, University of Maryland Medical Center, Baltimore. Shawn J. Kram, Pharm.D., BCPS, is Clinical Pharmacist, Duke University Hospital, Durham, NC. Michael J. Erdman, Pharm.D., BCPS, is Clinical Pharmacist, Neurocritical Care, University of Florida Health, Jacksonville. Gregory J. Peitz, Pharm.D., BCPS, is Clinical Assistant Professor, Department of Pharmacy Practice, College of Pharmacy, University of Nebraska Medical Center, Omaha. John M. Allen, Pharm.D., BCPS, is Assistant Professor, University of South Florida College of Pharmacy, Tampa. Allison Palmer, Pharm.D., BCPS, is Critical Care Clinical Pharmacist, John Peter Smith Hospital, Fort Worth, TX. Bridgette Kram, Pharm.D., BCPS, is Clinical Pharmacist, Duke University Hospital. Serena A. Harris, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Trauma and Surgical Critical Care, Eskenazi Health, Indianapolis, IN. Charles J Turck, Pharm.D., BCPS, is President and Chief Executive Officer, ScientiaCME, LLC, Mission Viejo, CA.
Purpose: Ten recently published articles with important implications for critical care pharmacotherapy are summarized.
Summary: The Critical Care Pharmacotherapy Literature Update (CCPLU) group is a national assembly of experienced intensive care unit (ICU) pharmacists across the United States. Group members monitor 25 peer-reviewed journals on an ongoing basis to identify literature relevant to pharmacy practice in the critical care setting.
Am J Health Syst Pharm
February 2015
Jared J. Butler, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Richard L. Roudebush Veterans Affairs Medical Center, Indianapolis, IN
Purpose: The use of an off-label dose of four-factor prothrombin complex concentrate (PCC) for International Normalized Ratio (INR) reversal in a patient before a diagnostic lumbar puncture is reported.
Summary: A 57-year-old, 122-kg man arrived at the hospital with a possible diagnosis of meningitis and had an INR of >3 while on warfarin therapy. The patient initiated warfarin therapy in 2009 due to recurrent deep vein thrombosis.
Am J Health Syst Pharm
February 2015
Ashley F. Harbison, Pharm.D., BCPS, is Clinical Pharmacist, The University of Kansas Hospital, Kansas City. Derek M. Polly, Pharm.D., is Clinical Pharmacy Specialist, Pulmonary/Critical Care Medicine, Emory University Hospital-Midtown, Atlanta, GA. Megan E. Musselman, Pharm.D., M.S., BCPS, is Clinical Pharmacy Specialist, Emergency Medicine/Critical Care, North Kansas City Hospital, Kansas City, MO.
Purpose: Special considerations in pharmacotherapy for infectious diseases in pregnant and lactating women in the emergency department (ED) setting are reviewed.
Summary: With many women turning to the ED as a source of primary care, it is essential for pharmacists involved in providing ED services to guide the selection of appropriate antiinfective agents during pregnancy and lactation; this area of practice is complicated by the very limited body of published data on the safety and efficacy of maternal antimicrobial use and potential fetal or neonatal adverse effects. Infectious diseases commonly encountered in the ED include sexually transmitted diseases, bacterial vaginosis and other vaginal infections, respiratory and urinary tract infections, and pneumonia.
Am J Health Syst Pharm
January 2015
Carmit K. McMullen, Ph.D., is Investigator, Kaiser Permanente Center for Health Research, Portland, OR. Tara A. Macey, Ph.D., is Assistant Professor, Oregon Health & Science University, Portland. Jill Pope, B.A., is Senior Technical Editor, Kaiser Permanente Center for Health Research. Brian Gugerty, D.N.S., RN, is Chief Executive Officer, GIC Informatics, Annapolis, MD. Marti Slot, Pharm.D., is Clinical Pharmacy Specialist, Informatics; and Peter Lundeen, M.D., is Physician Solutions Architect, Technology and Information Solutions, Spectrum Health, Grand Rapids, MI. Joan Ash, Ph.D., is Professor, Oregon Health & Science University. Neil Carlson, Ph.D., is Director, Center for Social Research, Calvin College, Grand Rapids.
Purpose: Pharmacists' satisfaction with a computerized prescriber order-entry (CPOE) system and the impact of CPOE on pharmacy workflows and order verification were investigated.
Summary: A mixed-method study was conducted to evaluate the implementation of a CPOE system in three hospitals of a large Michigan-based health system and early user experience with the system. Surveys of pharmacists before (n = 54) and after (n = 42) CPOE implementation indicated that they held generally positive expectations about CPOE prior to and during system implementation and continued to hold positive views about CPOE after several months of system use.
Am J Health Syst Pharm
January 2015
Susan J. Skledar, B.S., M.P.H., is Clinical Pharmacy Specialist, University of Pittsburgh Medical Center (UPMC), and Associate Professor, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA. Andrew Doedyns, B.S., M.B.A., is Pharmacy Manager, UPMC CancerCenter, Pittsburgh. Bryan Yourich, Pharm.D., is Regional Director of Pharmacy Operations, Department of Pharmacy, UPMC Shadyside, Pittsburgh.
Purpose: The transition to a hybrid model of oncology pharmacy services including remote order verification across a regional network of cancer centers is described.
Summary: Five years ago the University of Pittsburgh Medical Center (UPMC) began a major expansion of its cancer care services, gradually integrating 19 community-based physician practice sites into its tristate oncology network as affiliated hospital-based clinics (HBCs). The network expansion was achieved through a stepwise process including (1) development of oncology medication protocols, (2) interdisciplinary efforts to modify oncology care workflows, (3) implementation of a hybrid practice model to optimize the use of clinical pharmacy resources, and (4) focused staff training programs.
Am J Health Syst Pharm
January 2015
Haley G. Gibbs, Pharm. D., is Clinical Pharmacy Specialist, Department of Pharmacy, Johns Hopkins Hospital (JHH), Baltimore, MD. David E. Zimmerman, Pharm.D., is Assistant Professor of Pharmacy, Department of Clinical, Social, and Administrative Sciences, Mylan School of Pharmacy, Duquesne University, Pittsburgh, PA. Kenneth M. Shermock, Pharm.D., Ph. D., is Director of the Center for Medication Quality and Outcomes, Department of Pharmacy; William Clarke, Ph.D., is Associate Professor, Director of Clinical Toxicology, Department of Clinical Toxicology; Marek A. Mirski, M.D., Ph.D., is Vice-Chair and Director, Neuroscience Critical Care Unit, Department of Anesthesiology and Critical Care Medicine; and John J. Lewin III, Pharm.D., M.B.A., is Division Director, Critical Care and Surgery Pharmacy, Department of Pharmacy, and Adjunct Assistant Professor, Department of Anesthesiology and Critical Care Medicine, JHH.
Purpose: The differences in free fraction serum valproic acid concentrations between inpatients and outpatients were compared, and factors associated with therapeutic discordance were evaluated.
Methods: This retrospective, single-center, cross-sectional study included patients with both a free and a total valproic acid concentration drawn within 30 minutes of each other between January 7, 2003, and June 1, 2011. Serum valproic acid concentrations were stratified by admission status (inpatient versus outpatient).
Am J Health Syst Pharm
January 2015
Alex Dinh, B.S., is Medical Extern, Department of Medicine and Biomedical Sciences, SUNY at Buffalo, Buffalo, NY. Ashok Anathasayanan, M.D., is Nephrology Fellow, Department of Nephrology; and Lisa M. Rubin, Pharm.D., is Clinical Pharmacy Specialist, Nephrology and Formulary Management, Department of Pharmacy, Veterans Affairs Western New York Healthcare System, Buffalo.
Purpose: A severe case of Shiga toxin Escherichia coli (STEC)-associated hemolytic uremic syndrome (HUS) successfully treated with eculizumab is reported.
Summary: An 18-year-old man was admitted to the intensive care unit with HUS due to laboratory-confirmed STEC O121. He was initially treated with plasmapheresis and required hemodialysis for anuric acute kidney injury.
Am J Health Syst Pharm
December 2014
Adriane N. Irwin, M.S., Pharm.D., is Clinical Assistant Professor, Oregon State University College of Pharmacy, Corvallis; at the time of writing she was Clinical Pharmacy Research Fellow, Kaiser Permanente Colorado (KPCO), Aurora. Rachel M. F. Heilmann, Pharm.D., is Clinical Pharmacy Supervisor, KPCO, Denver, and Clinical Assistant Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Denver. Theresa M. Gerrity, Pharm.D., is Clinical Pharmacy Specialist, KPCO, Brighton. Beverly A. Kroner, Pharm.D., is Primary Care Clinical Pharmacy Services Chief, KPCO, Aurora. Kari L. Olson, Pharm.D., is Clinical Pharmacy Supervisor, KPCO, Aurora, and Clinical Associate Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences.
Purpose: The ability of a pharmacy technician to support the patient screening and documentation-related functions of a pharmacist-driven osteoporosis management service was evaluated.
Methods: A two-phase prospective study was conducted within a large integrated health system to assess a pharmacy technician's performance in supporting a multisite team of clinical pharmacy specialists providing postfracture care. In phase I of the study, a specially trained pharmacy technician provided support to pharmacists at five participating medical offices, helping to identify patients requiring pharmacist intervention and, when applicable, collecting patient-specific clinical information from the electronic health record.
Am J Health Syst Pharm
November 2014
Andrew S. Hunter, Pharm.D., BCPS, is Clinical Pharmacy Specialist-Infectious Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX. David J. Guervil, Pharm.D., is Clinical Pharmacy Specialist-Infectious Diseases, Memorial Hermann-Texas Medical Center, Houston. Katherine K. Perez, Pharm. D., BCPS, is Clinical Pharmacy Specialist-Infectious Diseases, Houston Methodist Hospital and Houston Methodist Research Institute, Houston. Amy N. Schilling, Pharm.D., BCPS, is Clinical Pharmacy Specialist-Infectious Diseases/Internal Medicine, Memorial Hermann-The Woodlands Hospital, The Woodlands, TX. Collin N. Verheyden, Pharm.D., BCPS, is Postgraduate Year 2 (PGY2) Infectious Diseases Pharmacy Resident, Michael E. DeBakey Veterans Affairs Medical Center. Nancy N. Vuong, Pharm.D., BCPS, is PGY2 Infectious Diseases Pharmacotherapy Resident, Cardinal Health and University of Houston College of Pharmacy, Houston. Ran Xu, Ph.D., Pharm.D., BCPS, is Clinical Pharmacy Manager, St. Luke's The Woodlands Hospital, The Woodlands.
Purpose: The most important articles on infectious diseases (ID) pharmacotherapy published in the peer-reviewed literature in 2013, as nominated and selected by panels of pharmacists and others with ID expertise, are summarized.
Summary: Members of the Houston Infectious Diseases Network were asked to nominate articles published last year in prominent biomedical journals that had a major impact in the field of ID pharmacotherapy. A list of 27 nominated articles on ID-related topics in general and 26 articles specifically focused on human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS) was compiled.
Am J Health Syst Pharm
November 2014
Rivka Siden, Pharm.D., M.S., is Clinical Pharmacy Specialist, Research Pharmacy, University of Michigan Health System (UMHS), Ann Arbor, and Adjunct Clinical Assistant Professor, University of Michigan College of Pharmacy (UMCP), Ann Arbor. Helen R. Tamer, Pharm. D., is Clinical Pharmacy Specialist, Research Pharmacy, UMHS, and Adjunct Clinical Assistant Professor, UMCP. Amy J., Skyles Pharm.D., is Clinical Pharmacy Specialist, Research Pharmacy, UMHS, and Adjunct Clinical Assistant Professor, UMCP. Christopher S. Dolan is Intern, Research Pharmacy, UMHS, and Pharm.D. student, UMCP. Denise J. Propes, CPhT, is Pharmacy Technician, Research Pharmacy, UMHS. Kimberly Redic, Pharm.D., BCPS, is Coordinator, Research Pharmacy, UMHS, and Clinical Assistant Professor, UMCP.
Purpose: Results of a survey assessing trends and innovations in the use of pharmacy technicians and other nonpharmacist staff in the research pharmacy setting are reported.
Methods: A Web-based survey was distributed to Internet communities of members of the American Society of Health-System Pharmacists and the University Health-System Consortium involved in investigational drug research and related practice areas. The survey collected data on the characteristics of institutions with pharmacy department staff dedicated to such research activities and the participation of pharmacists, technicians, and other staff in key areas of research pharmacy operations.
Am J Health Syst Pharm
November 2014
Adam Brancaccio, Pharm..D., BCPS, is Clinical Pharmacist Generalist-Internal Medicine, University of Michigan Health System, Ann Arbor, and Adjunct Clinical Faculty, University of Michigan College of Pharmacy, Ann Arbor; at the time of writing, he was Postgraduate Year 1 Pharmacy Practice Resident, Department of Pharmacy, St. John Hospital and Medical Center (SJHMC), Detroit, MI. Christopher Giuliano, Pharm.D., is Assistant Professor, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, and Clinical Specialist, Internal Medicine, Department of Pharmacy, SJHMC. Kelly McNorton, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Critical Care; and George Delgado Jr., Pharm.D., is Clinical Pharmacy Specialist, Emergency Medicine/Infectious Diseases, Department of Pharmacy, SJHMC.
Purpose: The use of a combined physician-and pharmacist-directed phenytoin loading dose program in an emergency department (ED) was evaluated.
Methods: This single-center, observational, preimplementation-postimplementation study evaluated adult patients who received a phenytoin loading dose in the ED. The primary outcome compared the proportion of optimal phenytoin loading doses in the preimplementation and postimplementation groups.
Am J Health Syst Pharm
October 2014
Ryan J. Bickel, Pharm.D., BCPS, is Pharmacy Manager, Borgess Pipp Hospital, Plainwell, MI. Curtis D. Collins, Pharm.D., M.S., FASHP, is Clinical Pharmacy Specialist, St. Joseph Mercy Health System, Ann Arbor, MI. Richard L. Lucarotti, Pharm.D., is Professor and Director of Experiential Education, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI. James G. Stevenson, Pharm.D., FASHP, is Chief Pharmacy Officer, University of Michigan Health System, Ann Arbor, and Professor and Associate Dean for Clinical Sciences, University of Michigan College of Pharmacy, Ann Arbor. Kathleen Pawlicki, M.S., FASHP, is Administrative Director, Professional Services, and Director of Pharmaceutical Services, Beaumont Hospital, Royal Oak, MI. Terry J. Baumann, Pharm.D., BCPS, DAAPM, is Clinical Manager, Pharmacy Department, Munson Medical Center, Traverse City, MI. Denise M. Pratt, Pharm.D., is Critical Care Clinical Pharmacist, Sparrow Hospital, Lansing, MI.
Purpose: Efforts to advance the ASHP Pharmacy Practice Model Initiative (PPMI) in the Michigan Society of Health-System Pharmacists (MSHP) are described.
Summary: After the Pharmacy Practice Model Summit in November 2010, the board of directors of MSHP began to strategize ways to help health-system pharmacists in Michigan achieve the vision and concepts envisioned by the PPMI. The ultimate goal was to develop a process for acting on recommendations developed by the PPMI to advance the practice of health-system pharmacy in Michigan.
Am J Health Syst Pharm
September 2014
Emily C. Pherson, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Internal Medicine, Johns Hopkins Hospital, Baltimore, MD. Kenneth M. Shermock, Pharm.D., Ph.D., is Director, Center for Medication Quality and Outcomes, Johns Hopkins Hospital, and Assistant Professor, General Internal Medicine, Johns Hopkins School of Medicine, Baltimore. Leigh E. Efird, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Internal Medicine; Vi T. Gilmore, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Internal Medicine; and Todd Nesbit, Pharm.D., M.B.A., is Associate Director, Decentralized and Clinical Services, Department of Pharmacy, Johns Hopkins Hospital. Yvonne LeBlanc, Pharm.D., M.B.A., CGP, is Associate Clinical Editor, Natural Standard Research Collaboration, Somerville, MA. Daniel J. Brotman, M.D., SFHM, FACP, is Director, Hospitalist Program, and Associate Professor of Medicine; Amy Deutschendorf, B.S.N., M.S.N., RN, ACNS-BC, is Senior Director, Utilization/Clinical Resource Management; and Meghan Davlin Swarthout, Pharm.D., M.B.A., BCPS, is Division Director, Ambulatory and Care Transitions, Department of Pharmacy, Johns Hopkins Hospital.
Purpose: The development and implementation of a postdischarge home-based, pharmacist-provided medication management service are described.
Summary: A work group composed of pharmacy administrators, clinical specialists, physicians, and nursing leadership developed the structure and training requirements to implement the service. Eligible patients were identified during their hospital admission by acute care pharmacists and consented for study participation.
Am J Health Syst Pharm
August 2014
Dennis K. Helling, Pharm.D., D.Sc., FCCP, FASHP, FAPhA, is Executive Director Emeritus, Pharmacy Operations and Therapeutics, Kaiser Permanente Colorado, and Clinical Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora. Samuel G. Johnson, Pharm.D., FCCP, BCPS (AQ-Cardiology), is Clinical Pharmacy Specialist-Applied Pharmacogenomics, Kaiser Permanente Colorado, and Clinical Assistant Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado.
Purpose: This paper reviews the basic tenets of ambulatory care pharmacy practice, including (1) the historical development of patient-centered care provided by pharmacists, (2) the need for and value of comprehensive medication management, (3) the education, training, and qualifications of pharmacists, and (4) demonstrated improvement in health and healthcare outcomes from pharmacists' services.
Summary: When ambulatory care pharmacists engage in patient care to their full capacity, physician time is saved, access to care is improved, and clinical and economic outcomes are enhanced. There is a need for ambulatory care pharmacists to work toward optimizing safe medication use and optimizing medication therapy for patients with diabetes, asthma, cardiovascular disease, and renal disease.
Am J Health Syst Pharm
July 2014
Dennis K. Helling, Pharm.D., D.Sc., FCCP, FASHP, FAPhA, is Executive Director Emeritus, Pharmacy Operations and Therapeutics, Kaiser Permanente Colorado, Aurora, and Clinical Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Denver. Samuel G. Johnson is Clinical Pharmacy Specialist-Applied Pharmacogenomics, Kaiser Permanente Colorado, and Clinical Assistant Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado.